0001209191-18-045819.txt : 20180808 0001209191-18-045819.hdr.sgml : 20180808 20180808161412 ACCESSION NUMBER: 0001209191-18-045819 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180806 FILED AS OF DATE: 20180808 DATE AS OF CHANGE: 20180808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horn Patrick Taylor CENTRAL INDEX KEY: 0001572002 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 181001502 MAIL ADDRESS: STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC. STREET 2: 480 ARSENAL STREET, SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-06 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001572002 Horn Patrick Taylor C/O ALBIREO PHARMA, INC. 10 POST OFFICE SQUARE, SUITE 502 SOUTH BOSTON MA 02109 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 31.54 2018-08-06 4 A 0 37500 0.00 A 2028-08-05 Common Stock 37500 37500 D This option vests and becomes exercisable as to 25% of the underlying shares on August 6, 2019 and the remainder in equal quarterly installments through the fourth anniversary of the date of grant. Jason Duncan, Attorney-in-fact 2018-08-08